Mettler-Toledo International (NYSE:MTD – Get Free Report) and Bio-Techne (NASDAQ:TECH – Get Free Report) are both large-cap healthcare companies, but which is the superior investment? Get Mettler-Toledo International alerts:Analyst RecommendationsThis is a breakdown of current ratings and target prices for Mettler-Toledo International and Bio-Techne, as reported by MarketBeat.com. Given Mettler-Toledo International’s stronger consensus rating and higher possible upside, research analysts clearly believe Mettler-Toledo International is more favorable than Bio-Techne. This table compares Mettler-Toledo International and Bio-Techne’s net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets Mettler-Toledo International 21.91% -1,212.14% 25.11% Bio-Techne 9.05% 13.57% 10.66%Institutional and Insider Ownership95.1% of Mettler-Toledo International shares are held by institutional investors.